136 related articles for article (PubMed ID: 14534854)
1. Bradykinin receptor antagonists in cerebral ischemia and trauma.
Zausinger S
IDrugs; 2003 Oct; 6(10):970-5. PubMed ID: 14534854
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
[TBL] [Abstract][Full Text] [Related]
3. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.
Gröger M; Lebesgue D; Pruneau D; Relton J; Kim SW; Nussberger J; Plesnila N
J Cereb Blood Flow Metab; 2005 Aug; 25(8):978-89. PubMed ID: 15815587
[TBL] [Abstract][Full Text] [Related]
4. Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia.
Zausinger S; Lumenta DB; Pruneau D; Schmid-Elsaesser R; Plesnila N; Baethmann A
Brain Res; 2002 Sep; 950(1-2):268-78. PubMed ID: 12231253
[TBL] [Abstract][Full Text] [Related]
5. Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition.
Su J; Cui M; Tang Y; Zhou H; Liu L; Dong Q
Biochem Biophys Res Commun; 2009 Oct; 388(2):205-11. PubMed ID: 19647718
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin receptor ligands: therapeutic perspectives.
Marceau F; Regoli D
Nat Rev Drug Discov; 2004 Oct; 3(10):845-52. PubMed ID: 15459675
[TBL] [Abstract][Full Text] [Related]
7. Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury.
Zweckberger K; Plesnila N
Neurosci Lett; 2009 Apr; 454(2):115-7. PubMed ID: 19429066
[TBL] [Abstract][Full Text] [Related]
8. Kinins and their receptors in hyperalgesia.
Dray A
Can J Physiol Pharmacol; 1997 Jun; 75(6):704-12. PubMed ID: 9276152
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats.
Kläsner B; Lumenta DB; Pruneau D; Zausinger S; Plesnila N
Neurochem Int; 2006 Oct; 49(5):442-7. PubMed ID: 16624448
[TBL] [Abstract][Full Text] [Related]
10. Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia.
Smith RS; Gao L; Chao L; Chao J
Biol Chem; 2008 Jun; 389(6):725-30. PubMed ID: 18627294
[TBL] [Abstract][Full Text] [Related]
11. Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury.
Chiang WC; Chien CT; Lin WW; Lin SL; Chen YM; Lai CF; Wu KD; Chao J; Tsai TJ
Free Radic Biol Med; 2006 Oct; 41(8):1304-14. PubMed ID: 17015177
[TBL] [Abstract][Full Text] [Related]
12. [Significance of kallikrein-kinin system in central nervous system diseases].
Stadnicka I; Strzałka-Mrozik B; Solarz K; Stadnicki A
Wiad Lek; 2018; 71(8):1615-1620. PubMed ID: 30684349
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin Receptors in Ischemic Injury.
Tang M; He F; Ma L; Liu P; Wang J; Zhu X
Curr Neurovasc Res; 2018; 15(4):359-366. PubMed ID: 30468128
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential for adenosine receptor activation in ischemic brain injury.
Miller LP; Hsu C
J Neurotrauma; 1992 May; 9 Suppl 2():S563-77. PubMed ID: 1613814
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin and neuronal injury.
Francel PC
J Neurotrauma; 1992 Mar; 9 Suppl 1():S27-45. PubMed ID: 1588616
[TBL] [Abstract][Full Text] [Related]
16. The kallikrein/kinin system and kinin antagonists in trauma.
Rodell TC
Immunopharmacology; 1996 Jun; 33(1-3):279-83. PubMed ID: 8856162
[TBL] [Abstract][Full Text] [Related]
17. Development of diabetic cardiomyopathy and the kallikrein-kinin system--new insights from B1 and B2 receptor signaling.
Tschöpe C; Westermann D
Biol Chem; 2008 Jun; 389(6):707-11. PubMed ID: 18627288
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
[TBL] [Abstract][Full Text] [Related]
19. Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.
Moodley R; Snyman C; Odhav B; Bhoola KD
Biol Chem; 2005 Apr; 386(4):375-82. PubMed ID: 15899700
[TBL] [Abstract][Full Text] [Related]
20. Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease.
Abraham WM; Scuri M; Farmer SG
Eur J Pharmacol; 2006 Mar; 533(1-3):215-21. PubMed ID: 16455073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
